MILAN/LONDON (Reuters) - European shares hit a two-week high on Thursday as strong results from Dutch bank ING and UK telecoms group BT helped offset a disappointing update from Credit Suisse, and ASM International brought some cheer to chipmakers.
The pan-European STOXX 600 hit a two-week high but then lost steam over the session, ending with a 0.2 percent gain. Germany's DAX .GDAXI declined 0.1 percent.
European shares built on Wednesday’s rally when fresh optimism over earnings helped ease worries over economic growth and political risk which sent the pan-European index close to two-year lows in October.
Miners, banks and retail - sectors highly sensitive to the economic cycle - led the gains, in a reversal of the pattern during the sell-off, which saw cyclicals underperform.
Britain's FTSE .FTSE lagged, down 0.5 percent, as the pound strengthened after a British official said London was close to sealing a deal that would give UK-based financial services firms basic access to EU markets.
ING (INGA.AS) shares rose 5.9 percent after the largest Dutch bank reported a better-than-expected profit of 776 million euros, as it continued to grow on an underlying basis despite being fined for failures to prevent money laundering.
“ING’s earnings are mainly boosted by the lower cost/income ratio as its cost cuts seem to start reaping benefits,” said Jauke de Jong, a research analyst at AFS Group in Amsterdam.
BT (BT.L) rallied 8.7 percent after it reported a better-than-expected 2 percent rise in first-half earnings and nudged its guidance for the full year higher. The stock was on track for its best day since May 2013.
Results from ING and BT lifted the banks and telecoms indexes up 0.9 and 2 percent respectively, bringing relief to sectors which have been among the worst perfomers so far this year in Europe and have suffered due to their poor earnings outlook.
ASM International (ASMI.AS) rallied 10.9 percent, its biggest one-day gain since 2009, after issuing a bullish outlook that countered fears of a downturn in the semiconductor market.
Leading the STOXX were two biotech firms, Morphosys and Argenx, which both surged.
Morphosys (MORG.DE) jumped 16.3 percent after it released encouraging results for its leukemia drug MOR 208. Argenx (ARGX.BR) gained 13.4 percent after new data for its Cusatuzumab drug, also to treat leukemia.
Credit Suisse (CSGN.S) was a weak spot.
Its shares fell 2.1 percent after its third-quarter net profit fell short of expectations, even after the bank said it would return to the black in the full year for the first time since Tidjane Thiam became chief executive in 2015.
Oil stocks fell after Shell (RDSa.AS) slightly missed expectations, sending its shares down 3.3 percent.
Weaker crude prices also weighed on the sector, down 2.6 percent.
The travel and leisure sector .SXTP - a laggard this year - had its best day since June 2016, up 2.6 percent.
Getinge (GETIb.ST) shares fell 7.9 percent after the U.S. Food & Drug Administration said it was evaluating recent reports of Getinge's intra-aortic balloon pump devices shutting down while running on battery power. bit.ly/2RzwBvZ
Shares in seismic oil services firm TGS (TGS.OL) dived 9.8 percent to their lowest since early May after its third quarter operating profit fell more than expected.
Wacker Chemie (WCHG.DE) gained 9.6 percent, with analysts saying the highly-shorted chemicals stock was benefiting from a NordLB upgrade to “buy”.
Overall, European earnings are expected to have risen 14.2 percent in the third quarter, up from a previous forecast of less than 13 percent, according to IBES Refinitiv data.
By the end of the week, companies representing around 40 percent of the STOXX 600’s market cap will have reported quarterly results.
Reporting by Danilo Masoni and Helen Reid; Editing by Josephine Mason and Andrew Roche